(Beaver Falls, Pa.) On this week’s episode of Living Well on Beaver County Radio at 8:30 AM Saturday morning Dr. Joseph Maroon and Jeff Bost, PAC, will present part two of a three parts series highlighting Dementia and Alzheimer’s Disease.

The series got under way last Saturday and will include the history of dementia related disease, typical symptoms, causes, risk factors, prevention and much more.

Dr. Joseph Maroon is a world renown neurosurgeon with extensive experience in neurosurgery. He specializes in minimally invasive surgery to speed recovery for his patients. He is a sports medicine expert and innovator in concussion management, personal fitness and nutrition. Dr. Maroon is also the Pittsburgh Steelers team doctor.

Jeff Bost  is a consultant to the St. Barnabas Health System. Bost is also a Clinical Instructor in the Department of Neurosurgery at University of Pittsburgh Medical Center, a consultant to the WWE, and Clinical Assistant Professor at Chatham University. He has a special interest in minimally invasive spine and brain surgery and have collaborated on scores of scientific medical papers and books in these areas. Over the last 15 years he has researched, lectured and written on the use of alternative treatment for pain control.

Bost, along with Dr. Joseph Maroon have authored two books on the use of omega-3 fish oil, including: Fish Oil: The Natural Anti-Inflammatory, currently in its forth printing with over 75,000 copies sold and recently, Why You Need Fish Oil. He has given over 100 invited lectures, 24 national posters and oral presentations, 29 coordinated research projects, five workshops presentations, 35 scientific articles and 10 book chapters.

You can rune into “Living Well” every Saturday morning at 8:30 on 95.7 and 99.3 FM, 1230 WBVP, 1460 WMBA, and beavercountyradio.com.

You can also listen to all previous episodes of “Living Well” by going to beavercountyradio.com clicking on the Listen Live Button, Then chose Beaver County Radio and click on Podcasts in the upper right hand corner.

You can also download our free apps by clicking on the proper store icon for your platform of a device:

Pastor Dave Grove reaches into the deeper meanings and analysis behind Psalm 103 in this week’s edition of “Wake Up Beaver Valley”, talking about the phase of “elder-ness” in life and in worship.

“Wake Up Beaver Valley” airs every Saturday morning from 9 AM to 10 AM on Beaver County Radio and is presented by the Church of The Redeemed of Beaver Valley. Archived editions of “Wake Up Beaver Valley” can be heard at the Beaver County Radio Podcast Library.

AHN oncologist/hematologist Dr. Diane Buchbarker and Veterans Breakfast Club member Larry Woods talk about their career journeys and daily motivations with host Jim Roddey on this week’s episode of “Heroes.”

“Heroes” is presented by Highmark Blue Cross/Blue Shield and the Allegheny Health Network, airing Saturdays at 10:00 AM and Sundays at 12:30 PM on Beaver County Radio. Archived editions of “Heroes” can be heard at the Beaver County Radio Podcast Library.

(File Photo taken by Beaver County Radio Staff)

• 
• 
• 
• 
• 
• 
• 

  https://patriothomecare.org/
• 
• 
• 
• 
• 
• 
• 

  Drug Free Aliquippa logo Facebook cover Oct 2020
• 
• 
• 
• 
• 
• 

    vs.

95.7 FM and1460 WMBA’s Rob Matzie and Bruce Frey have the call from Hopewell High School of this WPIAL Class 3A Western Hills Conference high school football game as the Vikings battle the Quakers.

If you can’t listen on the air you can listen to the game streaming live on the Trib-Live High School Sports Network by clicking on the logo below at game time.

This image provided by Amylyx Pharmaceuticals shows the drug Relyvrio. The much-debated drug for Lou Gehrig’s disease won approval by the U.S. Food and Drug Administration on Thursday, Sept. 29, 2022, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines. (Amylyx Pharmaceuticals via AP)
By MATTHEW PERRONE AP Health Writer
WASHINGTON (AP) — U.S. health officials have approved a much-debated drug to treat the deadly illness known as Lou Gehrig’s disease. The approval Thursday follows an intense lobbying campaign by patients and advocates, though it’s also likely to raise questions about the standards used to review experimental medicines. The Food and Drug Administration approved the medication from Amylyx Pharmaceuticals based on results from one small, mid-stage study. The agency’s internal scientists repeatedly said the company’s results were not convincing. But thousands of patients have urged the FDA to be flexible and grant patients’ access. Lou Gehrig’s disease has no cure and most patients die within five years of initial symptoms.